Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Kiora Pharmaceuticals Inc

NASDAQ: KPRX · Life Sciences · 3 alerts · CIK 1372514

Share price
$0.9820Close, Nov 16
Market cap
$4.34M
Shares outstanding
4.42MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Kiora Pharmaceuticals Inc filings on SEC EDGAR ↗

7:04 AM ET 8-K
Licensing Deal

Kiora Pharmaceuticals Licensing Deal with Senju Pharmaceutical Co., Ltd. Worth $3.5M

Kiora Pharmaceuticals entered into an exclusive license agreement with Senju Pharmaceutical to develop and commercialize KIO-401, a late-stage oral small-molecule calpain inhibitor for ophthalmic diseases, in all territories outside of Asia. Kiora will pay an upfront fee of $3.5 million, low teen millions upon technology transfer, and up to $168.5 million in potential regulatory and commercial milestones, plus single-digit royalties.

Value
$3.5M
Counterparty
Senju Pharmaceutical Co., Ltd.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.